Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecular Cancer Therapeutics|September 21, 2006
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agentKenneth W Yip, Emma Ito, Xinliang Mao, et al.Plos One|May 24, 2014
Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinomaJustin P Williams, Inki Kim, Emma Ito, et al.International Journal of Radiation Oncology, Biology, Physics|April 24, 2012
Excellence in Radiation Research for the 21st Century (EIRR21): description of an innovative research training programChristine P'ng, Emma Ito, Christine How, et al.Plos One|August 31, 2013
Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancerMichelle Lenarduzzi, Angela B Y Hui, Shijun Yue, et al.Cancer Research|March 10, 2011
MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathwayNehad M Alajez, Michelle Lenarduzzi, Emma Ito, et al.International Journal of Cancer|September 10, 2009
Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancerWei Shi, Nehad M Alajez, Carlo Bastianutto, et al.Molecular Pharmacology|August 6, 2009
Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancerEmma Ito, Kenneth W Yip, David Katz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Efficacy of combining GMX1777 with radiation therapy for human head and neck carcinomaHisayuki Kato, Emma Ito, Wei Shi, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 20, 2020
Radiation Oncology Fellowship: a Value-Based Assessment Among Graduates of a Mature ProgramEmma Ito, Fabio Y Moraes, Matthew Ramotar, et al.Science Translational Medicine|January 29, 2011
Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancerEmma Ito, Shijun Yue, Eduardo H Moriyama, et al.Pageof 2